Biologics and Biosimilars Barometer

25 000,00 

A unique study tracking EU-5 patients’ perceptions, experiences and awareness on their treatments for Rheumatology, Dermatology and Gastroenterology conditions.

Country

France, Germany, Italy, Spain, UK

Date

2017, 2018

Respondents

800

Format

PDF


Category:

Description

Deliverable

Pan European report with 150+ pages of in-depth analysis and recommandations.

Methodology

Ad hoc online research. All of Carenity’s community with conditions in scope were invited to participate by email: rheumatology (Rheumatoid Arthritis, Ankylosing Spondylitis), gastroenterology (Crohn’s disease, Ulcerative colitis) and dermatology (Psoriasis, Psoriatic Arthritis).

Frequency

Annual subscription – 1 wave / year

Objectives

  • Assess patient’s awareness and perception of biologics/biosimilars

  • Understand patients’ expectations on support and information

  • Evaluate patients’ perception of current biologics

  • Assess manufacturers awareness

Contact us